• OPEN AN ACCOUNT
Indian Indices
Nifty
25,195.80 113.50
(0.45%)
Sensex
82,570.91 317.45
( 0.39%)
Bank Nifty
57,006.65 241.30
( 0.43%)
Nifty IT
37,424.60 150.90
( 0.40%)
Global Indices
Nasdaq
44,472.11 79.59
(0.18%)
Dow Jones
6,289.33 8.58
(0.14%)
Hang Seng
39,646.81 187.19
(0.47%)
Nikkei 225
8,998.06 56.94
(0.64%)
Forex
USD-INR
85.82 0.14
(0.17%)
EUR-INR
100.30 -0.06
(-0.06%)
GBP-INR
115.75 -0.66
(-0.57%)
JPY-INR
0.58 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
94.39
403580.14
EPS(TTM)
Face Value()
Div & Yield %
17.82
1
0.95
 

sun pharmaceutical industries ltd
Sun Pharma updates on US FDA inspection
Jun 14,2025
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.